Childrens National Medical Center /ID# 253344

Washington D.C., District of Columbia 20010-2916

1 studies enrolling now · 1 studies all time

What they study most

Juvenile Idiopathic Arthritis

Studies at this site

• Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis. — Recruiting now